pmc logo imageJournal ListSearchpmc logo image
Logo of jcinvestCurrent issueArchiveSubscribe to the JCIAbout the JCIThe Journal of Clinical Investigation
J Clin Invest. 1985 November; 76(5): 1946–1949.
doi: 10.1172/JCI112192.
PMCID: PMC424248
3-Hydroxy-3-methylglutaryl coenzyme A reductase in anencephalic and normal human fetal liver.
B R Carr, W E Rainey, and J I Mason
Abstract
In previous investigations, we have found that the liver appears to be the major source of cholesterol in the human fetus, and, in particular, a principal source of circulating low density lipo-protein-cholesterol (LDL-C). LDL-C plasma levels are low in the normal fetus, most likely due to the rapid uptake and metabolism by the fetal adrenal as precursor for steroid hormone biosynthesis. In contrast, in the anencephalic fetus the adrenals are atrophic, the rate of estrogen and glucocorticoid production is low, and the levels of LDL-C in fetal plasma are high. The purpose of the present investigation was to determine the activity of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, the primary rate-limiting enzyme of cholesterol biosynthesis, in anencephalic liver and normal fetal liver. We found that the specific activity of HMG-CoA reductase in normal fetal liver microsomes was 0.428 +/- 0.054 nmol mevalonate formed times mg-1 protein X min-1 (mean +/- SE, n = 9). The rate of HMG-CoA reductase in anencephalic liver microsome preparations was 10-fold less (0.040 +/- 0.003) (mean +/- SE, n = 7) P less than 0.001. Furthermore, we detected HMG-CoA reductase (97,000-mol wt protein) in normal human fetal liver after SDS PAGE and immunoblotting by using a monoclonal antibody directed against HMG-CoA reductase. We were unable to detect any significant quantity of HMG-CoA reductase protein in anencephalic fetal liver, which indicates that low reductase activity was due to low amounts of enzyme protein rather than inactive enzyme. In summary, we conclude that the low levels of cholesterol synthesis observed in anencephalic fetal liver are probably due to both the high levels of LDL-C in fetal plasma as well as the presence of low circulating levels of estrogens and glucocorticoids and that these factors regulate cholesterol synthesis both in vivo and in vitro in fetal liver. This occurs most probably by the modulation of the amount of HMG-CoA reductase, a primary rate-limiting and regulatory enzyme of the cholesterol biosynthetic sequence.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (916K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Images in this article
Click on the image to see a larger version.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Carr, BR; Simpson, ER. Lipoprotein utilization and cholesterol synthesis by the human fetal adrenal gland. Endocr Rev. 1981 2(3):306–326.Summer; [PubMed]
  • Carr, BR; Simpson, ER. Cholesterol synthesis in human fetal tissues. J Clin Endocrinol Metab. 1982 Sep;55(3):447–452. [PubMed]
  • DAVIS, ME; GOULD, RG; LEROY, GV; PLOTZ, EJ; WERBIN, H. Hormones in human reproduction. I. Metabolism of progesterone. Am J Obstet Gynecol. 1956 Oct;72(4):740–755. [PubMed]
  • Hellig, H; Gattereau, D; Lefebvre, Y; Bolté, E. Steroid production from plasma cholesterol. I. Conversion of plasma cholesterol to placental progesterone in humans. J Clin Endocrinol Metab. 1970 May;30(5):624–631. [PubMed]
  • Lin, DS; Pitkin, RM; Connor, WE. Placental transfer of cholesterol into the human fetus. Am J Obstet Gynecol. 1977 Aug 1;128(7):735–739. [PubMed]
  • Das, SK; Foster, HW; Adhikary, PK; Mody, BB; Bhattacharyya, DK. Gestational variation of fatty acid composition of human amniotic fluid lipids. Obstet Gynecol. 1975 Apr;45(4):425–432. [PubMed]
  • Eisenberg, S; Levy, RI. Lipoprotein metabolism. Adv Lipid Res. 1975;13:1–89. [PubMed]
  • Zannis, VI; Kurnit, DM; Breslow, JL. Hepatic apo-A-I and apo-E and intestinal apo-A-I are synthesized in precursor isoprotein forms by organ cultures of human fetal tissues. J Biol Chem. 1982 Jan 10;257(1):536–544. [PubMed]
  • Parker, CR, Jr; Simpson, ER; Bilheimer, DW; Leveno, K; Carr, BR; MacDonald, PC. Inverse relation between low-density lipoprotein-cholesterol and dehydroisoandrosterone sulfate in human fetal plasma. Science. 1980 May 2;208(4443):512–514. [PubMed]
  • Parker, CR, Jr; Carr, BR; Winkel, CA; Casey, ML; Simpson, ER; MacDonald, PC. Hypercholesterolemia due to elevated low density lipoprotein-cholesterol in newborns with anencephaly and adrenal atrophy. J Clin Endocrinol Metab. 1983 Jul;57(1):37–43. [PubMed]
  • Carr, BR; Simpson, ER. Cholesterol synthesis by human fetal hepatocytes: effects of hormones. J Clin Endocrinol Metab. 1984 Jun;58(6):1111–1116. [PubMed]
  • Carr, BR; Simpson, ER. Cholesterol synthesis by human fetal hepatocytes: effect of lipoproteins. Am J Obstet Gynecol. 1984 Nov 1;150(5 Pt 1):551–557. [PubMed]
  • Parker, CR, Jr; Carr, BR; Simpson, ER; MacDonald, PC. Decline in the concentration of low-density lipoprotein-cholesterol in human fetal plasma near term. Metabolism. 1983 Sep;32(9):919–923. [PubMed]
  • BENIRSCHKE, K. Adrenals in anencephaly and hydrocephaly. Obstet Gynecol. 1956 Oct;8(4):412–425. [PubMed]
  • Gray, ES; Abramovich, DR. Morphologic features of the anencephalic adrenal gland in early pregnancy. Am J Obstet Gynecol. 1980 Jun 15;137(4):491–495. [PubMed]
  • Carr, BR; Ohashi, M; MacDonald, PC; Simpson, ER. Human anencephalic adrenal tissue: low density lipoprotein metabolism and cholesterol synthesis. J Clin Endocrinol Metab. 1981 Aug;53(2):406–411. [PubMed]
  • Ohashi, M; Carr, BR; Simpson, ER. Low density lipoprotein receptors in adrenal tissue of a human anencephalic fetus. Early Hum Dev. 1982 Nov;7(2):149–154. [PubMed]
  • Carr, BR; MacDonald, PC; Simpson, ER. The regulation of de novo synthesis of cholesterol in the human fetal adrenal gland by low density lipoprotein and adrenocorticotropin. Endocrinology. 1980 Oct;107(4):1000–1006. [PubMed]
  • Brown, MS; Dana, SE; Goldstein, JL. Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts by lipoproteins. Proc Natl Acad Sci U S A. 1973 Jul;70(7):2162–2166. [PubMed]
  • Carr, BR; Simpson, ER. Synthesis of cholesterol in the human fetus: 3-hydroxy-3-methylglutaryl coenzyme A reductase activity of liver microsomes. J Clin Endocrinol Metab. 1981 Oct;53(4):810–812. [PubMed]
  • LOWRY, OH; ROSEBROUGH, NJ; FARR, AL; RANDALL, RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed]
  • Laemmli, UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. [PubMed]
  • Burnette, WN. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem. 1981 Apr;112(2):195–203. [PubMed]
  • Johnson, DA; Elder, JH. Antibody directed to determinants of a Moloney virus derived MCF GP70 recognizes a thymic differentiation antigen. J Exp Med. 1983 Nov 1;158(5):1751–1756. [PubMed]
  • Liscum, L; Cummings, RD; Anderson, RG; DeMartino, GN; Goldstein, JL; Brown, MS. 3-Hydroxy-3-methylglutaryl-CoA reductase: a transmembrane glycoprotein of the endoplasmic reticulum with N-linked "high-mannose" oligosaccharides. Proc Natl Acad Sci U S A. 1983 Dec;80(23):7165–7169. [PubMed]
  • Beaufay, H; Amar-Costesec, A; Feytmans, E; Thinès-Sempoux, D; Wibo, M; Robbi, M; Berthet, J. Analytical study of microsomes and isolated subcellular membranes from rat liver. I. Biochemical methods. J Cell Biol. 1974 Apr;61(1):188–200. [PubMed]
  • Beg, ZH; Stonik, JA; Brewer, HB., Jr Human hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase: evidence for the regulation of enzymic activity by a bicyclic phosphorylation cascade. Biochem Biophys Res Commun. 1984 Mar 15;119(2):488–498. [PubMed]